{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:16:21Z","timestamp":1791180981218,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1245\/s10434-014-3524-x","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T11:06:42Z","timestamp":1392030402000},"page":"528-537","source":"Crossref","is-referenced-by-count":52,"title":["Near-Infrared Fluorescence Imaging of Both Colorectal Cancer and Ureters Using a Low-Dose Integrin Targeted Probe"],"prefix":"10.1245","volume":"21","author":[{"given":"Floris P. R.","family":"Verbeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost R.","family":"van der Vorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quirijn R. J. G.","family":"Tummers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karien E.","family":"de Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens W. G. M.","family":"L\u00f6wik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rob P. M.","family":"Valentijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J. H.","family":"van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Frangioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Vahrmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,11]]},"reference":[{"key":"3524_CR1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/bjs.7538","volume":"98","author":"AL Vahrmeijer","year":"2011","unstructured":"Vahrmeijer AL, Frangioni JV. Seeing the invisible during surgery. Br J Surg. 2011;98:749\u201350.","journal-title":"Br J Surg."},{"key":"3524_CR2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-5347(01)66332-8","volume":"155","author":"AA Selzman","year":"1996","unstructured":"Selzman AA, Spirnak JP. Iatrogenic ureteral injuries: a 20-year experience in treating 165 injuries. J Urol. 1996;155:878\u201381.","journal-title":"J Urol."},{"key":"3524_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0030-1263063","volume":"23","author":"SE Delacroix Jr","year":"2010","unstructured":"Delacroix SE, Jr., Winters JC. Urinary tract injuries: recognition and management. Clin Colon Rectal Surg. 2010;23:221.","journal-title":"Clin Colon Rectal Surg."},{"key":"3524_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1464-410x.2000.00100.x","volume":"86","author":"JM Preston","year":"2000","unstructured":"Preston JM. Iatrogenic ureteric injury: common medicolegal pitfalls. BJU Int. 2000;86:313\u20137.","journal-title":"BJU Int."},{"key":"3524_CR5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cbpa.2003.08.007","volume":"7","author":"JV Frangioni","year":"2003","unstructured":"Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol. 2003;7:626\u201334.","journal-title":"Curr Opin Chem Biol."},{"key":"3524_CR6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrclinonc.2013.123","volume":"10","author":"AL Vahrmeijer","year":"2013","unstructured":"Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013;10:507\u201318.","journal-title":"Nat Rev Clin Oncol."},{"key":"3524_CR7","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1245\/s10434-009-0609-z","volume":"16","author":"RG Pleijhuis","year":"2009","unstructured":"Pleijhuis RG, Graafland M, deVJ, Bart J, deJong JS, vanDam GM. (2009) Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol. 16:2717\u201330.","journal-title":"Ann Surg Oncol."},{"key":"3524_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2310\/7290.2011.00025","volume":"11","author":"S Oliveira","year":"2012","unstructured":"Oliveira S, van Dongen GA, Stigter-van WM, Roovers RC, Stam JC, Mali W, et al. Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody. Mol Imaging. 2012;11:33\u201346.","journal-title":"Mol Imaging."},{"key":"3524_CR9","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1245\/s10434-011-1664-9","volume":"18","author":"G Themelis","year":"2011","unstructured":"Themelis G, Harlaar NJ, Kelder W, Bart J, Sarantopoulos A, van Dam GM, et al. Enhancing surgical vision by using real-time imaging of alphavbeta3-integrin targeted near-infrared fluorescent agent. Ann Surg Oncol. 2011;18:3506\u201313.","journal-title":"Ann Surg Oncol."},{"key":"3524_CR10","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1245\/s10434-012-2435-y","volume":"19","author":"CH Heath","year":"2012","unstructured":"Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol. 2012;19:3879\u201387.","journal-title":"Ann Surg Oncol."},{"key":"3524_CR11","doi-asserted-by":"crossref","first-page":"S693","DOI":"10.1245\/s10434-013-3172-6","volume":"20","author":"CA Metildi","year":"2013","unstructured":"Metildi CA, Tang CM, Kaushal S, Leonard SY, Magistri P, Tran Cao HS, et al. (2013) In vivo fluorescence imaging of gastrointestinal stromal tumors using fluorophore-conjugated anti-KIT antibody. Ann Surg Oncol. 20:693\u2013700.","journal-title":"Ann Surg Oncol."},{"key":"3524_CR12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jss.2011.01.009","volume":"174","author":"JR Vorst van der","year":"2011","unstructured":"van der Vorst JR, Hutteman M, Mieog JS, de Rooij KE, Kaijzel EL, L\u00f6wik CW, et al. Near-infrared fluorescence imaging of liver metastases in rats using indocyanine green. J Surg Res. 2011;174:266\u201371.","journal-title":"J Surg Res."},{"key":"3524_CR13","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ijc.27430","volume":"131","author":"S Keereweer","year":"2012","unstructured":"Keereweer S, Mol IM, Vahrmeijer AL, VanDriel PB, BaatenburgdeJong RJ, Kerrebijn JD, et al. (2012) Dual wavelength tumor targeting for detection of hypopharyngeal cancer using near-infrared optical imaging in an animal model. Int J Cancer. 131:1633\u201340.","journal-title":"Int J Cancer."},{"key":"3524_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11307-006-0041-8","volume":"8","author":"Y Wu","year":"2006","unstructured":"Wu Y, Cai W, Chen X. Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers. Mol Imaging Biol. 2006;8:226\u201336.","journal-title":"Mol Imaging Biol."},{"key":"3524_CR15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nbt.2468","volume":"31","author":"HS Choi","year":"2013","unstructured":"Choi HS, Gibbs SL, Lee JH, Kim SH, Ashitate Y, Liu F, et al. Targeted zwitterionic near-infrared fluorophores for improved optical imaging. Nat Biotechnol. 2013;31:148\u201353.","journal-title":"Nat Biotechnol."},{"key":"3524_CR16","author":"CA Metildi","year":"2013","unstructured":"Metildi CA, Kaushal S, Luiken GA, Talamini MA, Hoffman RM, Bouvet M. (2013) Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model. J Surg Oncol. doi: 10.1002\/jso.23507 .","journal-title":"J Surg Oncol"},{"key":"3524_CR17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/cbic.201200034","volume":"13","author":"A Bunschoten","year":"2012","unstructured":"Bunschoten A, Buckle T, Visser N, Kuil J, Yuan H, Josephson L, et al. Multimodal interventional molecular imaging of tumor margins and distant metastases using the integrin avB3 expression. ChemBioChem. 2012;13:1039\u201345.","journal-title":"ChemBioChem."},{"key":"3524_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11912-006-0043-3","volume":"8","author":"GC Tucker","year":"2006","unstructured":"Tucker GC. Integrins: molecular targets in cancer therapy. Curr Oncol Rep. 2006;8:96\u2013103.","journal-title":"Curr Oncol Rep."},{"key":"3524_CR19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00441-009-0834-6","volume":"339","author":"M Barczyk","year":"2010","unstructured":"Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. 2010;339:269\u201380.","journal-title":"Cell Tissue Res."},{"key":"3524_CR20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev.cellbio.12.1.697","volume":"12","author":"E Ruoslahti","year":"1996","unstructured":"Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697\u2013715.","journal-title":"Annu Rev Cell Dev Biol."},{"key":"3524_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","volume":"2","author":"JD Hood","year":"2002","unstructured":"Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2002;2:91\u2013100.","journal-title":"Nat Rev Cancer."},{"key":"3524_CR22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/modpathol.3880447","volume":"14","author":"A Vonlaufen","year":"2001","unstructured":"Vonlaufen A, Wiedle G, Borisch B, Birrer S, Luder P, Imhof BA. Integrin alpha(v)beta(3) expression in colon carcinoma correlates with survival. Mod Pathol. 2001;14:1126\u201332.","journal-title":"Mod Pathol."},{"key":"3524_CR23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/modpathol.3880447","volume":"14","author":"A Vonlaufen","year":"2001","unstructured":"Vonlaufen A, Wiedle G, Borisch B, Birrer S, Luder P, Imhof BA. Integrin alpha(v)beta(3) expression in colon carcinoma correlates with survival. Mod Pathol. 2001;14:1126\u201332.","journal-title":"Mod Pathol."},{"key":"3524_CR24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<320::AID-IJC2>3.0.CO;2-#","volume":"71","author":"R Max","year":"1997","unstructured":"Max R, Gerritsen RR, Nooijen PT, Goodman SL, Sutter A, Keilholz U, et al. Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. Int J Cancer. 1997;71:320\u20134.","journal-title":"Int J Cancer."},{"key":"3524_CR25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/02841850903273974","volume":"51","author":"R Axelsson","year":"2010","unstructured":"Axelsson R, Bach-Gansmo T, Castell-Conesa J, McParland BJ. An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha(v)beta(3)-selective angiogenesis imaging agent (99m)Tc-NC100692. Acta Radiol. 2010;51:40\u20136.","journal-title":"Acta Radiol."},{"key":"3524_CR26","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1158\/1078-0432.CCR-12-0374","volume":"18","author":"R Huang","year":"2012","unstructured":"Huang R, Vider J, Kovar JL, Olive DM, Mellinghoff IK, Mayer-Kuckuk P, et al. Integrin \u03b1vbeta3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res. 2012;18:5731\u201340.","journal-title":"Clin Cancer Res."},{"key":"3524_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2310\/7290.2009.00014","volume":"8","author":"WB Edwards","year":"2009","unstructured":"Edwards WB, Akers WJ, Ye Y, Cheney PP, Bloch S, Xu B, et al. Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide. Mol Imaging. 2009;8:101\u201310.","journal-title":"Mol Imaging."},{"key":"3524_CR28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno\/v01p0048","volume":"1","author":"AJ Beer","year":"2011","unstructured":"Beer AJ, Kessler H, Wester HJ, Schwaiger M. PET imaging of integrin alphaVbeta3 expression. Theranostics. 2011;1:48\u201357.","journal-title":"Theranostics."},{"key":"3524_CR29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ygyno.2012.12.011","volume":"128","author":"NJ Harlaar","year":"2013","unstructured":"Harlaar NJ, Kelder W, Sarantopoulos A, Bart J, Themelis G, van Dam GM, et al. Real-time near infrared fluorescence (NIRF) intra-operative imaging in ovarian cancer using an alpha(v)beta(3-)integrin targeted agent. Gynecol Oncol. 2013;128:590\u20135.","journal-title":"Gynecol Oncol."},{"key":"3524_CR30","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1158\/1078-0432.CCR-06-0266","volume":"12","author":"AJ Beer","year":"2006","unstructured":"Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL, et al. Positron emission tomography using [18F]galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res. 2006;12:3942\u20139.","journal-title":"Clin Cancer Res."},{"key":"3524_CR31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2967\/jnumed.107.045526","volume":"49","author":"AJ Beer","year":"2008","unstructured":"Beer AJ, Niemeyer M, Carlsen J, Sarbia M, N\u00e4hrig J, Watzlowik P, et al. Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-galacto-RGD PET. J Nucl Med. 2008;49:255\u20139.","journal-title":"J Nucl Med."},{"key":"3524_CR32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1215\/15228517-2009-024","volume":"11","author":"O Schnell","year":"2009","unstructured":"Schnell O, Krebs B, Carlsen J, Miederer I, Goetz C, Goldbrunner RH, et al. Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] galacto-RGD positron emission tomography. Neuro Oncol. 2009;11:861\u201370.","journal-title":"Neuro Oncol."},{"key":"3524_CR33","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1002\/anie.201102459","volume":"50","author":"HS Choi","year":"2011","unstructured":"Choi HS, Nasr K, Alyabyev S, Feith D, Lee JH, Kim SH, et al. Synthesis and in vivo fate of zwitterionic near-infrared fluorophores. Angew Chem Int Ed Engl. 2011;50:6258\u201363.","journal-title":"Angew Chem Int Ed Engl."},{"key":"3524_CR34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.nucmedbio.2012.02.006","volume":"39","author":"K Pohle","year":"2012","unstructured":"Pohle K, Notni J, Bussemer J, Kessler H, Schwaiger M, Beer AJ. 68\u00a0Ga-NODAGA-RGD is a suitable substitute for (18F)-galacto-RGD and can be produced with high specific activity in a cGMP\/GRP compliant automated process. Nucl Med Biol. 2012;39:777\u201384.","journal-title":"Nucl Med Biol."},{"key":"3524_CR35","first-page":"484","volume":"10","author":"W Tseng","year":"2007","unstructured":"Tseng W, Leong X, Engleman E. Orthotopic mouse model of colorectal cancer. J Vis Exp. 2007;(10):484.","journal-title":"J Vis Exp."},{"key":"3524_CR36","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1245\/s10434-009-0594-2","volume":"16","author":"SL Troyan","year":"2009","unstructured":"Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, Oketokoun R, et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol. 2009;16:2943\u201352.","journal-title":"Ann Surg Oncol."},{"key":"3524_CR37","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1118\/1.1573791","volume":"30","author":"X Intes","year":"2003","unstructured":"Intes X, Ripoll J, Chen Y, Nioka S, Yodh AG, Chance B. In vivo continuous-wave optical breast imaging enhanced with indocyanine green. Med Phys. 2003;30:1039\u201347.","journal-title":"Med Phys."},{"key":"3524_CR38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jso.22102","volume":"105","author":"S Keereweer","year":"2012","unstructured":"Keereweer S, Mol IM, Kerrebijn JD, VanDriel PB, Xie B, BaatenburgdeJong RJ, et al. (2012) Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer. J Surg Oncol. 105:714\u20138.","journal-title":"J Surg Oncol."},{"key":"3524_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/138955711793564024","volume":"11","author":"JL Arias","year":"2011","unstructured":"Arias JL. Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem. 2011;11:1\u201317.","journal-title":"Mini Rev Med Chem."},{"key":"3524_CR40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271\u201384.","journal-title":"J Control Release."},{"key":"3524_CR41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","volume":"63","author":"J Fang","year":"2011","unstructured":"Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136\u201351.","journal-title":"Adv Drug Deliv Rev."},{"key":"3524_CR42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.juro.2013.02.3187","volume":"190","author":"FP Verbeek","year":"2013","unstructured":"Verbeek FP, van der Vorst JR, Schaafsma BE, Swijnenburg RJ, Gaarenstroom KN, Elzevier HW, et al. Intraoperative near infrared fluorescence guided identification of the ureters using low dose methylene blue: a first in human experience. J Urol. 2013;190:574\u20139.","journal-title":"J Urol."},{"key":"3524_CR43","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s11605-012-1945-z","volume":"16","author":"DA Sherwinter","year":"2012","unstructured":"Sherwinter DA. Identification of anomolous biliary anatomy using near-infrared cholangiography. J Gastrointest Surg. 2012;16:1814\u20135.","journal-title":"J Gastrointest Surg."},{"key":"3524_CR44","doi-asserted-by":"crossref","unstructured":"Verbeek FP, Schaafsma BE, Tummers QR, van der Vorst JR, van der Made WJ, Baeten CI, et al. Optimization of near-infrared fluorescence cholangiography for open and laparoscopic surgery. Surg Endosc. 2013 (in press).","DOI":"10.1007\/s00464-013-3305-9"},{"key":"3524_CR45","first-page":"1333","volume":"46","author":"AJ Beer","year":"2005","unstructured":"Beer AJ, Haubner R, Goebel M, Luderschmidt S, Spilker ME, Wester HJ, et al. Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med. 2005;46:1333\u201341.","journal-title":"J Nucl Med."},{"key":"3524_CR46","first-page":"1781","volume":"61","author":"R Haubner","year":"2001","unstructured":"Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, et al. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 2001;61:1781\u20135.","journal-title":"Cancer Res."},{"key":"3524_CR47","unstructured":"US Department of Health and Human Services, Center for Drug Evaluation and Research. Guidance for industry, investigators, and reviewers exploratory IND studies. Rockville, MD: US Department of Health and Human Services; 2006."},{"key":"3524_CR48","doi-asserted-by":"crossref","first-page":"134ps11","DOI":"10.1126\/scitranslmed.3003572","volume":"4","author":"W Scheuer","year":"2012","unstructured":"Scheuer W, van Dam GM, Dobosz M, Schwaiger M, Ntziachristos V. Drug-based optical agents: infiltrating clinics at lower risk. Sci Transl Med. 2012; 4: 134ps11.","journal-title":"Sci Transl Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3524-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3524-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3524-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T09:51:27Z","timestamp":1565171487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3524-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,11]]},"references-count":48,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3524"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3524-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,11]]}}}